PRESS RELEASE published on 05/09/2023 at 07:30, 1 year 6 months ago APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition year in focusing on Single Pills
PRESS RELEASE published on 05/08/2023 at 07:30, 1 year 6 months ago APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development partnership with Zentiva Group for another Single Pill with EU-wide intellectual property rights
PRESS RELEASE published on 05/03/2023 at 13:00, 1 year 6 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Bioleaching Potential for the W4 Nickel Sulphides
PRESS RELEASE published on 05/02/2023 at 21:50, 1 year 6 months ago EQS-Adhoc: APONTIS PHARMA AG adjusts forecast for fiscal year 2023
PRESS RELEASE published on 04/27/2023 at 07:30, 1 year 6 months ago APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary prophylaxis of cardiovascular events - market launch already planned for early 2024
PRESS RELEASE published on 04/20/2023 at 13:00, 1 year 7 months ago EVNi Clean Nickel(TM) R&D - Preliminary Results Confirm Carbon Capture and Storage ("CCS") Potential of the CarLang Area
PRESS RELEASE published on 04/12/2023 at 13:00, 1 year 7 months ago EV Nickel Announces Filing of NI 43-101 Technical Report for Previously Announced CarLang Project Maiden Resource
PRESS RELEASE published on 04/12/2023 at 07:30, 1 year 7 months ago APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio with EU-wide property rights opens up additional revenue potential
PRESS RELEASE published on 03/28/2023 at 13:00, 1 year 7 months ago EV Nickel Continues to Expand the High-Grade W4 Zone with Impressive Nickel Drill Hole Intercepts Including 13.1m Grading 1.47% Ni and 2.1m Grading 3.01% Ni
PRESS RELEASE published on 03/09/2023 at 07:30, 1 year 8 months ago APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded according to preliminary calculations
Published on 11/21/2024 at 17:35, 21 minutes ago 1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Published on 11/21/2024 at 17:30, 26 minutes ago SimpliGov and Proof Partner to Offer Online Notarization
Published on 11/21/2024 at 16:30, 1 hour 26 minutes ago The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Published on 11/21/2024 at 16:01, 1 hour 55 minutes ago Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Published on 11/21/2024 at 16:00, 1 hour 56 minutes ago Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight
Published on 11/21/2024 at 15:41, 2 hours 15 minutes ago Edison issues report on Murray Income Trust (MUT)
Published on 11/21/2024 at 15:24, 2 hours 32 minutes ago Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 2 hours 33 minutes ago Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 2 hours 34 minutes ago Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 06:58, 10 hours 58 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 22 hours 36 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 10 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
